全球医疗设备软体市场

预计到 2030 年全球医疗设备软体市场规模将达到 5,370 万美元

2024 年全球医疗设备软体市场规模估计为 2,220 万美元，预计到 2030 年将达到 5,370 万美元，2024 年至 2030 年的复合年增长率为 15.9%。云端运算采用是报告中分析的细分市场之一，预计复合年增长率为 14.1%，到分析期结束时规模将达到 3,200 万美元。在分析期内，内部配置部分预计将以 18.8% 的复合年增长率成长。

美国市场规模估计为 600 万美元，中国市场预计复合年增长率为 20.7%

美国医疗设备软体市场规模预计在2024年达到600万美元。作为世界第二大经济体的中国，预计2030年市场规模将达到1,160万美元，在2024-2030年分析期间的复合年增长率为20.7%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 11.9% 和 14.1%。在欧洲，预计德国的复合年增长率约为 12.6%。

全球软体医疗设备市场－主要趋势与驱动因素摘要

只用代码就能治疗吗？为什么软体作为医疗设备将重新定义医疗保健

软体即医疗设备(SaMD) 透过使独立于硬体的软体程式能够执行诊断、治疗建议和疾病监测等功能，彻底改变了医疗保健。与嵌入设备的传统软体不同，SaMD 可以在行动装置、云端平台或桌面应用程式上自主运行，从而实现远端患者管理和数据驱动的临床决策。从使用智慧型手机上的心电图演算法检测心律不整到使用预测糖尿病软体优化胰岛素剂量，SaMD 正在改变医疗保健的提供方式，特别是在慢性病管理、心理健康、放射学和数位治疗领域。

SaMD 尤其具有颠覆性，因为它能够大规模提供临床能力，而无需物理製造。这种灵活性使得快速更新、迭代改进和即时数据分析成为可能——所有这些对于管理肿瘤学、神经病学和罕见疾病等复杂疾病至关重要。此外，COVID-19 疫情加速了用于远距离诊断和数位分诊的 SaMD 工具的检验，为 FDA 和 EMA 等监管机构建立快速核准通道铺平了道路。对个人化、非侵入性和持续监测解决方案的需求从未如此强烈，这使得 SaMD 成为不断发展的护理的基石。

为什么从製药公司到付款人的相关人员支持 SaMD？

云端处理、人工智慧和行动技术的融合为在临床和消费者环境中部署 SaMD 创造了肥沃的环境。製药公司正在加速将 SaMD 整合到其药物开发和上市后监测策略中，利用数位生物标记和真实世界数据来改善治疗结果并监测患者的依从性。这些软体解决方案还与伴随诊断、连接药物输送设备和穿戴式感测器捆绑在一起，形成一个全面的数位健康生态系统。对于付款人和提供者，SaMD 提供早期检测、风险分层和介入的工具，从而降低住院率并提高成本效益。

监管机构正在透过建立确保患者安全且不抑制创新的框架来应对。 FDA 的数位健康软体预认证计画、欧盟的医疗设备法规 (MDR) 和日本的药品和医疗设备管理局 (PMDA) 都为 SaMD 引入了简化的途径。这些框架强调上市后监测、以使用者为中心的设计和真实世界的效能检验。 SaMD 独立于硬体运行，使其能够跨地域快速扩展，在资源受限的医疗保健环境中特别有效。随着基于价值的照护模式在全球的扩展，SaMD 有望成为主动、个人化医疗保健领域的核心。

人工智慧、机器学习和现实世界数据如何推动 SaMD 的发展？

人工智慧和机器学习是 SaMD 创新的核心。这些技术使软体能够分析大量资料集、识别模式并做出高精度的预测评估。在放射学领域，人工智慧 SaMD 可以从影像扫描中检测出肿瘤和骨折等异常情况，其准确度可与人类专家媲美甚至超过人类专家。在心臟病学中，机器学习演算法评估心电图讯号以寻找心律不整和心臟衰竭的指标。在行为健康领域，SaMD 解决方案经过训练，可以透过语音模式、面部表情和数位互动数据检测焦虑和忧郁的早期征兆。这些功能不仅提高了诊断的准确性，而且还能够实现更早、更个人化的介入。

真实世界数据 (RWD) 和真实世界证据 (RWE) 进一步推动了 SaMD 的价值提案。由于软体平台整合了穿戴式装置、电子健康记录和病患报告结果的数据，它成为持续学习和即时风险评估的有力工具。开发人员正在利用云端基础设施和联合学习模型来提高不同人群的演算法效能，同时确保资料隐私。这样的回馈迴路将允许监管机构核准自适应演算法——根据新证据在核准后不断发展的 SaMD 产品。整合网路安全、HIPAA 合规性和使用者身分验证系统可确保这些解决方案的安全可靠。

是什么推动了医疗设备软体的快速成长？

数位健康产业的多种协同力量推动着软体医疗设备市场的成长。其中最重要的是，对于慢性病和文明病的远距照护和自我管理工具的需求日益增长。随着患者越来越依赖行动应用程式和连网平台来监测他们的健康状况，SaMD 正在弥合临床环境和居家照护之间的差距。此外，新兴市场智慧型手机和云端基础设施的广泛采用正在使 SaMD 的存取变得民主化，使服务不足的人群能够从人工智慧主导的医疗保健解决方案中受益。

製药和医疗技术公司正在迅速将 SaMD 纳入其市场进入策略，因为他们认为这是扩大其产品治疗影响和收集上市后见解的一种方式。同时，医院和付款人正在利用 SaMD 进行自动分类、病人参与和早期检测，以减轻急诊的压力并改善护理协调。最后，创业投资和私募股权对 SaMD新兴企业的投资达到了历史最高水平，显示市场信心强劲。随着医疗保健系统朝向个人化、以数据为中心、预防保健模式发展，SaMD 将成为全球医疗保健服务的临床工具和策略差异化因素。

部分

部署（云端、本地）、应用（筛检和诊断、监测和警报、慢性疾病管理、数位治疗、其他应用）、最终用途（医院和诊所、居家医疗、其他最终用途）

受访公司范例（43家值得关注的公司）

• AliveCor
• Apple Inc.
• Arterys Inc.
• Biofourmis
• Brainlab
• Cerner Corporation
• Digital Diagnostics Inc.
• GE Healthcare
• Google Health
• Health Catalyst
• IBM Watson Health
• iSchemaView Inc.
• Medtronic plc
• MindMaze
• Microsoft Health
• Philips Healthcare
• Qlarity Imaging LLC
• Samsung Health
• Siemens Healthineers
• Viz.ai

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口（成品和OEM）预测公司竞争地位的变化。这种复杂且多方面的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组等微观和宏观市场动态。

全球产业分析师密切关注世界领先的首席经济学家（14,949）、智库（62）和贸易及产业协会（171）的专家意见，以评估生态系统的影响并应对新的市场现实。各主要国家的专家和经济学家都在关注关税及其对国家的影响。

全球产业分析师预计，这种动盪将在未来几个月内平息，新的世界秩序将更加明确地建立。全球产业分析师正在即时追踪这些发展。

2025年4月：谈判阶段

我们四月份的发布将涵盖关税对全球市场整体的影响，并为各地区的市场调整提供指导。我们的预测是基于历史数据和不断发展的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将于 7 月收到免费更新。最终更新包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业和领域专家的最具影响力的首席经济学家，他们共用了全球经济状况这一前所未有的模式转移的影响。我们的 16,491 多份报告中的大多数都遵循这个基于两阶段里程碑的发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Software as a Medical Device Market to Reach US$53.7 Million by 2030

The global market for Software as a Medical Device estimated at US$22.2 Million in the year 2024, is expected to reach US$53.7 Million by 2030, growing at a CAGR of 15.9% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 14.1% CAGR and reach US$32.0 Million by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 18.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.0 Million While China is Forecast to Grow at 20.7% CAGR

The Software as a Medical Device market in the U.S. is estimated at US$6.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.6 Million by the year 2030 trailing a CAGR of 20.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

Global Software as a Medical Device Market - Key Trends & Drivers Summarized

Can Code Alone Cure? Why Software as a Medical Device Is Rewriting Healthcare Norms

Software as a Medical Device (SaMD) is revolutionizing healthcare by allowing software programs-independent of any hardware-to perform functions such as diagnosis, treatment recommendation, or disease monitoring. Unlike traditional software embedded within devices, SaMD operates autonomously on mobile devices, cloud platforms, or desktop applications, enabling remote patient management and data-driven clinical decision-making. From detecting cardiac arrhythmias via smartphone ECG algorithms to optimizing insulin dosing through predictive diabetes software, SaMD is transforming how healthcare is delivered, particularly in chronic disease management, mental health, radiology, and digital therapeutics.

What makes SaMD particularly disruptive is its ability to deliver clinical functionality at scale without the need for physical manufacturing. This agility allows rapid updates, iterative improvements, and real-time data analysis-all essential in managing complex conditions like oncology, neurology, and rare diseases. Additionally, the COVID-19 pandemic accelerated the validation of SaMD tools for remote diagnostics and digital triage, paving the way for regulatory agencies like the FDA and EMA to establish fast-track pathways for their approval. The demand for personalized, non-invasive, and continuous monitoring solutions has never been higher, positioning SaMD as a linchpin in the evolving continuum of care.

Why Are Stakeholders from Pharma to Payers Rallying Behind SaMD?

The convergence of cloud computing, artificial intelligence, and mobile technologies has created a fertile environment for SaMD deployment across both clinical and consumer settings. Pharmaceutical companies are increasingly integrating SaMD into their drug development and post-marketing surveillance strategies, using digital biomarkers and real-world data to enhance therapeutic efficacy and monitor patient adherence. These software solutions are also being bundled with companion diagnostics, connected drug delivery devices, and wearable sensors to form comprehensive digital health ecosystems. For payers and providers, SaMD offers tools for early detection, risk stratification, and intervention that can reduce hospitalization rates and improve cost efficiency.

Regulatory bodies have responded by establishing frameworks that ensure patient safety without stifling innovation. The FDA’s Digital Health Software Precertification Program, the EU Medical Device Regulation (MDR), and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) have introduced streamlined pathways tailored for SaMD. These frameworks emphasize post-market surveillance, user-centric design, and real-world performance validation. SaMD’s ability to operate independently of hardware allows it to scale rapidly across geographies, making it especially effective in resource-constrained healthcare settings. As value-based care models expand globally, SaMD is poised to become a core enabler of proactive, personalized healthcare.

How Are AI, Machine Learning, and Real-World Data Powering SaMD Evolution?

Artificial intelligence and machine learning are at the heart of SaMD innovation. These technologies allow software to analyze vast datasets, identify patterns, and make predictive assessments with high precision. In radiology, AI-powered SaMD can detect abnormalities such as tumors or fractures from imaging scans with accuracy comparable to or exceeding human specialists. In cardiology, ML algorithms assess ECG signals for arrhythmias or heart failure indicators. In behavioral health, SaMD solutions are being trained to detect early signs of anxiety or depression through speech patterns, facial expressions, and digital interaction data. These capabilities are not just enhancing diagnostic accuracy but enabling earlier and more personalized interventions.

Real-world data (RWD) and real-world evidence (RWE) are further propelling the value proposition of SaMD. As software platforms integrate data from wearables, electronic health records, and patient-reported outcomes, they become powerful tools for continuous learning and real-time risk assessment. Developers are leveraging cloud infrastructure and federated learning models to ensure data privacy while improving algorithmic performance across diverse populations. This feedback loop is enabling regulatory agencies to approve adaptive algorithms-SaMD products that evolve post-approval based on new evidence. The integration of cybersecurity, HIPAA compliance, and user authentication systems ensures that these solutions remain secure and trustworthy.

What’s Fueling the Exponential Rise of Software as a Medical Device?

The growth in the software as a medical device market is driven by several synergistic forces across the digital health landscape. Chief among them is the escalating demand for remote care and self-management tools, especially in chronic and lifestyle-driven diseases. With patients increasingly relying on mobile apps and connected platforms to monitor their health, SaMD is bridging the gap between clinical settings and home-based care. Moreover, the proliferation of smartphones and cloud infrastructure in emerging markets is democratizing access to SaMD, allowing underserved populations to benefit from AI-driven healthcare solutions.

Pharmaceutical and medtech companies are rapidly incorporating SaMD into their go-to-market strategies, viewing it as a means to extend the therapeutic impact of their products and gather post-market insights. Meanwhile, hospitals and payers are leveraging SaMD for triage automation, patient engagement, and early detection to reduce the burden on emergency departments and improve care coordination. Finally, venture capital and private equity investment in SaMD startups is at an all-time high, signaling strong market confidence. As healthcare systems evolve toward personalized, data-centric, and preventive care models, SaMD is positioned to serve as both a clinical tool and a strategic differentiator in global healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Software as a Medical Device market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Deployment (Cloud, On-Premise); Application (Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics, Other Applications); End-Use (Hospitals & Clinics, Home Care Settings, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• AliveCor
• Apple Inc.
• Arterys Inc.
• Biofourmis
• Brainlab
• Cerner Corporation
• Digital Diagnostics Inc.
• GE Healthcare
• Google Health
• Health Catalyst
• IBM Watson Health
• iSchemaView Inc.
• Medtronic plc
• MindMaze
• Microsoft Health
• Philips Healthcare
• Qlarity Imaging LLC
• Samsung Health
• Siemens Healthineers
• Viz.ai

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Software as a Medical Device - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Regulatory Recognition of Software-Based Therapeutics Drives Market Legitimacy and Growth
  • Accelerated Adoption of Digital Health and Remote Monitoring Expands Application Scope
  • Increased Investment in AI-Powered Diagnostics and Predictive Algorithms Fuels Innovation
  • Widespread Use in Chronic Disease Management Strengthens Clinical Integration
  • Mobile and Wearable Integration Enhances Real-Time Patient Engagement
  • Regulatory Frameworks Like FDA and EU MDR Enable Clarity and Global Expansion
  • Use in Personalized Medicine and Data-Driven Treatment Planning Expands Precision Health Opportunities
  • Mental Health and Behavioral Therapy Applications Create Rapid Adoption Pathways
  • Reimbursement Inclusion in Select Markets Drives Payor-Supported Growth
  • Cybersecurity and Data Integrity Challenges Highlight the Need for Robust Infrastructure
  • Partnerships Between Tech Startups and Medical Device Firms Accelerate Product Development
  • Rise in Clinical Validation and Real-World Evidence Collection Strengthens Market Trust
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Software as a Medical Device Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Software as a Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Screening & Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Screening & Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Screening & Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Monitoring & Alerting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Monitoring & Alerting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Monitoring & Alerting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Chronic Disease Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Chronic Disease Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Chronic Disease Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Software as a Medical Device by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Software as a Medical Device by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Software as a Medical Device by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Software as a Medical Device by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION